Bone is a common site for metastasis of solid cancers, but histological and molecular features of bone metastases are not ...

A seminal decision concerning second medical use patents and questions over confidentiality were among the top talking points ...

In the latest episode of Touching Base, we discuss big news in CRISPR along with updates in the business side of biotech.

Element has responded to the lawsuit with a statement saying, “Element is proud of its strong history of innovation. We are ...

Get our top picks of the posters at AACR 2025 and learn more about the method behind them and the techniques used.

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has reached a settlement ...

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-reports-first-quarter-2025-financial-results-302450468.html SOURCE ...

comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how 10x Genomics performed in the just reported ...

Founded in 2012 by scientists seeking to overcome limitations in traditional biological research methods, 10x Genomics (NASDAQ:TXG) develops instruments, consumables, and software that enable ...

PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $34.4 million in its first quarter. The Pleasanton, California-based company said it ...